Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 5,714,775 | 5,617,599 | -97,176 | $163.90M | $181.06M | 13.47% | +$17.16M |
| Standard BioTools Inc.(LAB) | 1,200,000 | 61,907,605 | +60,707,605 | $2.65M | $167.77M | 12.48% | +$165.12M |
| Biolife Solutions Inc | 8,707,165 | 8,707,165 | 0 | $141.49M | $161.52M | 12.02% | +$20.03M |
| Sarepta Therapeutics, Inc.(SRPT) | 1,006,500 | 1,069,000 | +62,500 | $97.06M | $138.39M | 10.30% | +$41.34M |
| Relay Therapeutics, Inc.(RLAY) | 7,387,943 | 7,423,574 | +35,631 | $81.34M | $61.62M | 4.59% | -$19.73M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 195,000 | 358,000 | +163,000 | $37.32M | $53.50M | 3.98% | +$16.18M |
| Avidity Biosciences Inc | 1,175,750 | 2,084,841 | +909,091 | $10.64M | $53.21M | 3.96% | +$42.56M |
| Intellia Therapeutics, Inc.(NTLA) | 1,450,000 | 1,875,000 | +425,000 | $44.21M | $51.58M | 3.84% | +$7.37M |
| Structure Therapeutics IncADS | 1,091,867 | 1,116,867 | +25,000 | $44.50M | $47.87M | 3.56% | +$3.36M |
| Endeavour Silver Corp.(EXK) | 420,000 | 650,000 | +230,000 | $31.07M | $44.89M | 3.34% | +$13.82M |
| Verve Therapeutics Inc | 3,009,094 | 3,059,094 | +50,000 | $41.95M | $40.62M | 3.02% | -$1.32M |
| Tenaya Therapeutics, Inc.(TNYA) | 6,381,377 | 6,732,971 | +351,594 | $20.68M | $35.21M | 2.62% | +$14.54M |
| Illumina, Inc.(ILMN) | 313,000 | 248,000 | -65,000 | $43.58M | $34.06M | 2.53% | -$9.53M |
| Blueprint Medicines Corp | 326,378 | 326,378 | 0 | $30.11M | $30.96M | 2.30% | +$855.1K |
| GeneDx Holdings Corp.CL A(WGS) | 3,095,511 | 3,136,411 | +40,900 | $8.51M | $28.64M | 2.13% | +$20.12M |
| Neurogene Inc.(NGNE) | 524,616 | 524,616 | 0 | $10.17M | $26.70M | 1.99% | +$16.54M |
| Denali Therapeutics Inc.(DNLI) | 1,300,000 | 1,300,000 | 0 | $27.90M | $26.68M | 1.99% | -$1.22M |
| 4d Molecular Therapeutics In | 1,033,811 | 800,000 | -233,811 | $20.95M | $25.49M | 1.90% | +$4.54M |
| Beam Therapeutics Inc.(BEAM) | 528,000 | 675,000 | +147,000 | $14.37M | $22.30M | 1.66% | +$7.93M |
| Veracyte, Inc.(VCYT) | 0 | 857,904 | +857,904 | $0 | $19.01M | 1.41% | +$19.01M |
| Pliant Therapeutics, Inc.(PLRX) | 1,577,108 | 1,000,000 | -577,108 | $28.56M | $14.90M | 1.11% | -$13.66M |
| Century Therapeutics, Inc.(IPSC) | 3,206,380 | 3,206,380 | 0 | $10.65M | $13.40M | 1.00% | +$2.76M |
| 2seventy Bio Inc | 1,182,623 | 2,000,000 | +817,377 | $5.05M | $10.70M | 0.80% | +$5.65M |
| AbCellera Biologics Inc.(ABCL) | 2,360,129 | 2,360,129 | 0 | $13.48M | $10.69M | 0.80% | -$2.78M |
| Tango Therapeutics, Inc.(TNGX) | 1,188,349 | 1,188,349 | 0 | $11.76M | $9.44M | 0.70% | -$2.33M |
| Codexis, Inc.(CDXS) | 2,000,000 | 2,000,000 | 0 | $6.10M | $6.98M | 0.52% | +$880.0K |
| Absci Corporation | 973,260 | 973,260 | 0 | $4.09M | $5.53M | 0.41% | +$1.44M |
| Pacific Biosciences of California, Inc.(PACB) | 1,035,859 | 1,035,859 | 0 | $10.16M | $3.88M | 0.29% | -$6.28M |
| Kyverna Therapeutics, Inc.(KYTX) | 0 | 150,000 | +150,000 | $0 | $3.73M | 0.28% | +$3.73M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 510,882 | 510,882 | 0 | $2.89M | $3.60M | 0.27% | +$715.2K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 150,000 | 150,000 | 0 | $3.24M | $3.57M | 0.27% | +$328.5K |
| Prime Medicine, Inc.(PRME) | 367,175 | 367,175 | 0 | $3.25M | $2.57M | 0.19% | -$682.9K |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 0 | 1,459,747 | +1,459,747 | $0 | $1.69M | 0.13% | +$1.69M |
| Exscientia PlcADS | 213,900 | 213,900 | 0 | $1.37M | $1.22M | 0.09% | -$147.6K |
| Singular Genomics Systems In | 1,323,885 | 1,323,885 | 0 | $609.1K | $680.7K | 0.05% | +$71.6K |
| Kronos Bio Inc | 123,839 | 123,839 | 0 | $154.8K | $161.0K | 0.01% | +$6.2K |
| Fate Therapeutics, Inc.(FATE) | 2,050,000 | 0 | -2,050,000 | $7.67M | $0 | — | -$7.67M |
| LianMedicalADS(LIANY) | 206,415 | 0 | -206,415 | $922.7K | $0 | — | -$922.7K |
| Somalogic IncCL A | 12,604,275 | 0 | -12,604,275 | $31.89M | $0 | — | -$31.89M |